Cost Navigation

GLP-1 Insurance Coverage — We Help You Navigate It

GLP-1 medications can cost over $1,000/month without coverage. Physicians on the FirstCall platform assist with prior authorization and identify every cost-reduction option.

At a glance

GLP-1 Insurance Concierge — prior authorization help

The GLP-1 Insurance Concierge service helps navigate prior authorization paperwork for Wegovy®, Zepbound®, Ozempic®, and other GLP-1 medications. Coverage decisions vary widely by plan and employer benefit design. The Concierge service prepares documentation, manages plan communications, and tracks appeals — increasing the chance of approval and saving you the back-and-forth. Cash-pay options at the lowest available price are also available when insurance isn't an option.

What it covers
prior authorization paperwork, plan communication, appeals
Medications supported
Wegovy®, Zepbound®, Ozempic®, compounded options
If insurance denies
cash-pay program options at the lowest available price

Educational content. Last clinically reviewed by the FirstCall Clinical Editorial Board, June 2026. The FirstCall platform provides access to independent, licensed physicians; final clinical decisions rest with the prescribing physician.

$149
Wegovy® pill self-pay starting price
$25
typical insured co-pay with savings programs
PA
prior authorization required for most plans
Free
A physician on the FirstCall platform PA assistance
The Coverage Landscape

GLP-1 insurance — why it's complicated

Coverage for GLP-1 weight loss medications varies more than almost any other drug class.

GLP-1 medications have two FDA approval categories: weight management (Wegovy®, Zepbound®) and type 2 diabetes (Ozempic®, Mounjaro®). Most insurance plans cover GLP-1s for type 2 diabetes far more readily than for obesity — even though the clinical benefits are equally well documented.

Prior authorization is required by most plans for any GLP-1 prescription. PA requirements typically include documented BMI, at least one qualifying comorbidity, evidence of prior weight loss attempts, and physician documentation of medical necessity. The physician you're connected with handles this at no extra charge.

PA documentation prepared by your physician at no extra charge
Coverage assessment for your specific plan and employer
Manufacturer savings programs and co-pay cards identified
Self-pay alternatives recommended if insurance denies
Insurance Navigation
Coverage by Plan Type

What different plans typically cover

Commercial / employer plans
Coverage expanding

Employer plans are increasingly covering GLP-1s for obesity. PA required — BMI plus comorbidity documentation typically needed.

PA required with BMI and comorbidity documentation
Savings cards can reduce co-pays to $0–$25/month
Appeal process available for initial denials
Employer wellness programs may offer alternative access
Medicare Part D
Limited but expanding

Wegovy® now covered for patients with established cardiovascular disease under Part D.

Covered for Wegovy® with established CVD indication
Not yet broadly covered for obesity without CVD
Medicare Advantage plans may offer expanded coverage
Check your specific Part D plan formulary
Medicaid
State by state

Medicaid GLP-1 coverage varies by state. Most states cover for type 2 diabetes but not specifically for obesity.

Coverage determined by individual state formularies
Type 2 diabetes indication typically covered more broadly
Coverage expanding as clinical evidence accumulates
Self-pay options
Always available

The Wegovy® pill launched at $149/month in January 2026 — the most affordable GLP-1 entry point in history.

Wegovy® pill: starting at $149/month self-pay
Compounded semaglutide: typically lower cost
Manufacturer savings programs reduce branded costs
HSA/FSA eligible — use pre-tax dollars
The PA Process

How prior authorization works with FirstCall

1
Physician evaluation

The physician you're connected with documents your BMI, comorbidities, and medical necessity in clinical terms that meet PA requirements.

2
PA submission

Physician submits prior authorization to your insurance with clinical documentation and supporting evidence.

3
Insurer review

Typical review takes 3–15 business days. Urgent requests can be expedited. Your physician advocates for approval.

4
Approval or appeal

If approved, prescription proceeds at co-pay rate. If denied, physician assists with the appeals process and advises on self-pay alternatives.

Common Questions

Frequently asked questions

Clear answers about your GLP-1 program.

Standard PA documentation includes: current BMI, qualifying comorbidity diagnosis (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, or CVD), evidence of prior weight loss attempts, and physician attestation of medical necessity. The physician you're connected with prepares this at no additional charge.
Denial on first submission is common but not final. Your physician can prepare and submit a formal appeal. If unsuccessful, your physician advises on the most cost-effective self-pay alternative — beginning with the Wegovy® pill at $149/month.
Coverage for the Wegovy® pill is being established as of early 2026. Your physician can verify your plan's current coverage and advise on whether the pill or injection is more likely to receive approval under your specific plan.
Yes. GLP-1 medications prescribed for a qualifying medical condition are eligible for HSA and FSA funds — allowing you to pay with pre-tax dollars and effectively reduce your out-of-pocket cost by your marginal tax rate.

Related programs

All options available through Physicians on the FirstCall platform.

Wegovy® Pill
Wegovy® Pill
$149/month — most affordable GLP-1
Compounded GLP-1
Compounded GLP-1
lower-cost compounded alternative
Ongoing Care
Ongoing Care
continuous support through treatment

Get your GLP-1 evaluation today.

Insurance assessment included. Self-pay options from $149/month.